Promethium Advisors »

Abbvie shares owned by Promethium Advisors

Quarter-by-quarter ownership of Abbvie (ABBV) shares owned by Promethium Advisors from 13F filings

Historical chart of Promethium Advisors investment in Abbvie

Tip: Access up to 7 years of quarterly data

All positions including Abbvie held by Promethium Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abbvie by Promethium Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $3.1M 16k 197.48

More positions owned by Promethium Advisors

Apple (AAPL)
Thomson Reuters Corp. (TRI)
Pfizer (PFE)
Bristol Myers Squibb (BMY)
Broadstone Net Lease (BNL)
T. Rowe Price (TROW)
Texas Pacific Land Corp (TPL)
Alphabet Cap Stk Cl A (GOOGL)
Danaher Corporation (DHR)
Alphabet Cap Stk Cl C (GOOG)
Abbvie (ABBV)
Cme (CME)
Ishares Tr U.s. Tech Etf (IYW)
Johnson & Johnson (JNJ)
Spdr Ser Tr Bloomberg 3-12 M (BILS)

View all positions for Promethium Advisors

Top funds holding Abbvie

Vanguard Group
BlackRock
BlackRock
State Street Corporation
Jpmorgan Chase & Co
Morgan Stanley
Capital Research and Management Company - Division 3
Geode Capital Management
Capital Research Global Investors
Charles Schwab Investment Management
Bank of America Corporation
Northern Trust
Bank of New York Mellon
Capital World Investors
Franklin Resources

View all funds holding Abbvie